Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol

A Bhan, I Hussain, KI Ansari, S Kasiri, A Bashyal… - Journal of molecular …, 2013 - Elsevier
Journal of molecular biology, 2013Elsevier
Abstract HOTAIR (HOX antisense intergenic RNA) is a long noncoding RNA (lncRNA) that is
transcribed from the antisense strand of homeobox C gene locus in chromosome 12.
HOTAIR coordinates with chromatin-modifying enzymes and regulates gene silencing. It is
overexpressed in various carcinomas including breast cancer. Herein, we demonstrated that
HOTAIR is crucial for cell growth and viability and its knockdown induced apoptosis in breast
cancer cells. We also demonstrated that HOTAIR is transcriptionally induced by estradiol …
Abstract
HOTAIR (HOX antisense intergenic RNA) is a long noncoding RNA (lncRNA) that is transcribed from the antisense strand of homeobox C gene locus in chromosome 12. HOTAIR coordinates with chromatin-modifying enzymes and regulates gene silencing. It is overexpressed in various carcinomas including breast cancer. Herein, we demonstrated that HOTAIR is crucial for cell growth and viability and its knockdown induced apoptosis in breast cancer cells. We also demonstrated that HOTAIR is transcriptionally induced by estradiol (E2). Its promoter contains multiple functional estrogen response elements (EREs). Estrogen receptors (ERs) along with various ER coregulators such as histone methylases MLL1 (mixed lineage leukemia 1) and MLL3 and CREB-binding protein/p300 bind to the promoter of HOTAIR in an E2-dependent manner. Level of histone H3 lysine-4 trimethylation, histone acetylation, and RNA polymerase II recruitment is enriched at the HOTAIR promoter in the presence of E2. Knockdown of ERs and MLLs downregulated the E2-induced HOTAIR expression. Thus, similar to protein-coding gene transcription, E2-induced transcription of antisense transcript HOTAIR is coordinated via ERs and ER coregulators, and this mechanism of HOTAIR overexpression potentially contributes towards breast cancer progression.
Elsevier